Clinical Trials Browser

Terminated × donafenib × Gastrointestinal × Clear all

NCT05171166 2025-12-18

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Phase 2/3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT02489201 2023-06-15

A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms